Sinovac Biotech, Ltd.

The momentum for this stock is not very good. Sinovac Biotech, Ltd. is not very popular among insiders. Sinovac Biotech, Ltd. is a mediocre stock to choose.

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture,...

News

Sinovac Biotech Experiences 2024 Mid-Year Downturn

TipRanks Financial Blog Sinovac Biotech (SVA) has released an update. Sinovac Biotech Ltd. reported a downturn in its financial performance for the first half of 2024, with revenues fallin...\n more…

SINOVAC Reports Unaudited First Half of 2024 Financial Results

Business Wire Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June...\n more…

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

Business Wire Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and...\n more…

Sinovac Amends Shareholder Rights Plan

Business Wire Sinovac Biotech Ltd. (Sinovac or the Company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights...\n more…

Sinovac Biotech board rejects partial tender offer by Alternative Liquidity

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer

Business Wire Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the Board of Directors...\n more…